Veeva Systems Inc  

(Public, NYSE:VEEV)   Watch this stock  
Find more results for Mark S. Wallach�
28.00
+0.17 (0.61%)
Nov 21 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 27.91 - 28.43
52 week 17.11 - 44.30
Open 28.24
Vol / Avg. 497,188.00/655,748.00
Mkt cap 3.59B
P/E 151.08
Div/yield     -
EPS 0.19
Shares 51.32M
Beta     -
Inst. own 110%
Nov 25, 2014
Q3 2015 Veeva Systems Inc Earnings Call - 4:30PM EST - Add to calendar
Nov 25, 2014
Q3 2015 Veeva Systems Inc Earnings Release - 4:00PM EST - Add to calendar
Sep 9, 2014
Veeva Systems Inc at Deutsche Bank Technology Conference
Sep 8, 2014
Veeva Systems Inc at Morgan Stanley Healthcare Conference
Sep 3, 2014
Veeva Systems Inc at Citi Global Technology Conference
Aug 28, 2014
Q2 2015 Veeva Systems Inc Earnings Call
Aug 28, 2014
Q2 2015 Veeva Systems Inc Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '14) 2014
Net profit margin 12.66% 11.24%
Operating margin 22.18% 18.70%
EBITD margin - 19.85%
Return on average assets 8.54% 10.26%
Return on average equity 11.07% 6.78%
Employees 815 -
CDP Score - -

Address

Suite 210, 4637 Chabot Drive
PLEASANTON, CA 94588
United States - Map
+1-925-4526500 (Phone)
+1-925-4526504 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Veeva Systems Inc. (Veeva) which provides industry-specific, cloud-based software solutions for the life sciences industry. Veeva delivers industry-specific cloud-based solutions including data, software, and services to the global life sciences industry. The Company's solutions enable pharmaceutical and other life sciences companies. As of January 31, 2013, it served 51, 95 and 134 life sciences customers, respectively. As of August 31, 2013, it served approximately 170 life sciences customers, including 33 of the 50 largest global pharmaceutical companies. The Company's solutions have been implemented in over 75 countries.

Officers and directors

Gordon Ritter Chairman of the Board
Age: 49
Bio & Compensation  - Reuters
Matthew J. Wallach President, Co-Founder
Age: 41
Bio & Compensation  - Reuters
Peter P. Gassner Chief Executive Officer, Founder, Director
Age: 49
Bio & Compensation  - Reuters
TIMOTHY S CABRAL Chief Financial Officer
Age: 46
Bio & Compensation  - Reuters
Josh Faddis Vice President, General Counsel, Corporate Secretary
Age: 42
Bio & Compensation  - Reuters
Paul J. Sekhri Director
Age: 55
Bio & Compensation  - Reuters
Mark Armenante Independent Director
Age: 61
Bio & Compensation  - Reuters
Ronald E.F. Codd Independent Director
Age: 58
Bio & Compensation  - Reuters